AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback